Lupin Limited has informed the Exchange regarding a press release dated March 07, 2025, titled "Lupin Launches Rivaroxaban Tablets USP, 2.5 mg in the United States".
Lupin Limited has informed the Exchange regarding a press release dated March 07, 2025, titled "Lupin Launches Rivaroxaban Tablets USP, 2.5 mg in the United States".